This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:osteoarthritis [01.05.2019] – [Research] sallieq | home:diseases:osteoarthritis [01.11.2019] – [Introduction] sallieq | ||
---|---|---|---|
Line 8: | Line 8: | ||
+ | Usefulness of broad-range PCR for the diagnosis of osteoarticular infections.(({{pubmed> | ||
===== Evidence of infectious cause ===== | ===== Evidence of infectious cause ===== | ||
Line 16: | Line 16: | ||
- | Sample PubMed cite(({{pubmed> | + | |
===== Accepted knowledge ===== | ===== Accepted knowledge ===== | ||
[[http:// | [[http:// | ||
Line 54: | Line 54: | ||
Altogether, our data show that tetracyclines have no inhibitory potential on any proteoglycanolytic activities within mild or moderately affected human OA cartilage at therapeutic achievable plasma levels. | Altogether, our data show that tetracyclines have no inhibitory potential on any proteoglycanolytic activities within mild or moderately affected human OA cartilage at therapeutic achievable plasma levels. | ||
- | Biomarkers of early stage osteoarthritis, | + | Biomarkers of early stage osteoarthritis, |
+ | |||
+ | After adjusting for all the covariates, the relative odds (95% confidence interval) of developing definite knee OA per increment of 1 SD (20.7 ng/mL) in winter season 25(OH)D was 1.57 (1.10-2.27), | ||
+ | CONCLUSION: The results do not support the hypothesis that a low level of serum 25(OH)D contributes to the development of OA. (({{pubmed> | ||
| | ||
- | {{tag> | + | {{tag> |
- | < | ||